97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-JapicCTI-194721 | 01/6/2019 | 17/04/2019 | A Phase I Study of RO7021610 in Patients with Ulcerative Colitis | A Phase I Multiple-Dose Study of RO7021610 in Japanese Patients with Ulcerative Colitis | Ulcerative colitis | Intervention name : RO7021610 INN of the intervention : Efmarodocokin alfa Dosage And administration of the intervention : RO7021610 will be administrated repeatedly by IV. Control intervention name : Placebo INN of the control intervention : - Dosage And administration of the control intervention : Placebo will be administrated repeatedly by IV. | Chugai Pharmaceutical Co., Ltd. | NULL | complete | 18 | 80 | BOTH | 24 | Phase 1 | Japan |